DUAL INHIBITION OF THE TWO SOURCES OF CHOLESTEROL. THE MODERN METHODOLOGY OF REDUCING CARDIOVASCULAR RISC

Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 2

Abstract

This study evaluated the efficacy and safety of Ezetimibe co-administered with Simvastatine therapy in 104 hypercholesterolemic patients with coronary heart disease (CHD) or diabetes who had not achieved their low-density lipoprotein cholesterol (LDL-C) goal <100mg/dl while on a stable dose of Simvastatine 20mg/day. Significantly more patients achieved an LDL-C goal <100mg/dl with Ezetimibe than Placebo (51% vs. 35%). Compared to Placebo, co-administration of Ezetimibe with Simvastatine led to significantly greater reductions in LDL-C, total cholesterol, triglycerides, non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B; HDL-C was as well increased. Co-administration of Ezetimibe and Simvastatine was well tolerated, with an overall safety profile similar to Simvastatine alone.

Authors and Affiliations

Gabriela Dale, M. I. Popescu, Loredana Popa, A. R. Popa, R. Fritsch

Keywords

Related Articles

METABOLIC SYNDROME IN PATIENTS WITH T1DM OLDER THAN 10 YEARS

Metabolic Syndrome (MS) is a clinical entity recently individualized, a clinical concept with multiple definitions that expresses a complex disorder of the body′s energy metabolism, with insulin resistance and compensato...

THE LINK BETWEEN DIABETES, DIABETES TREATMENT AND CANCER

Diabetes mellitus (DM) and cancer are serious diseases, representing a great social burden worldwide and their association has been studied over the years. Several risk factors are common to both DM and cancer and result...

DIABETES IN PREGNANCY: PREPREGNANCY CARE FOR TYPE 1 AND TYPE 2 DIABETES

Preconception counseling is the education of, and the discussion with, women of reproductive age about pregnancy and contraception. It is essential component of every consultation in primary and/or specialist care. Preco...

Blood Pressure Profile And Glycemic Profile T1DM

The main objective of this study is to analyze the blood pressure profile of patients with type 1 diabetes mellitus and the aspect of the glycemic profile in order to identify the correlations between blood pressure and...

PANCREAS TRANSPLANTATION – BENEFITS AND RISKS FOR DIABETIC PATIENTS

Pancreas transplantation is considered a valuable therapeutic option in diabetic patients, either alone or combined with renal allografts in transplant candidates with imminent or established end-stage renal disease. Imp...

Download PDF file
  • EP ID EP155379
  • DOI -
  • Views 121
  • Downloads 0

How To Cite

Gabriela Dale, M. I. Popescu, Loredana Popa, A. R. Popa, R. Fritsch (2011). DUAL INHIBITION OF THE TWO SOURCES OF CHOLESTEROL. THE MODERN METHODOLOGY OF REDUCING CARDIOVASCULAR RISC. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 18(2), 151-156. https://europub.co.uk/articles/-A-155379